AFT Pharmaceuticals Limited Profit Margin

AFT Pharmaceuticals Limited (AFP.AX) currently reports a profit margin of 5.77% as of March 2026. That compares with 7.46% in the prior-year period — down 22.7% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore AFT Pharmaceuticals Limited's profit margin history and peer comparisons.

AFT Pharmaceuticals Limited's profit margin decreased from 7.46% to 5.77% — a 22.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AFT Pharmaceuticals Limited's profit margin of 5.77% is lower than the its sector sector average of 13.23%. That is roughly 56.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but AFT Pharmaceuticals Limited's current 5.77% should be judged against industry norms (sector average: 13.23%) and against AFP.AX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 5.77%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for AFT Pharmaceuticals Limited, and consider following AFP.AX for alerts when major investors trade the stock.